Strategies and challenges for the next generation of therapeutic antibodies

被引：636
|
作者：
Beck, Alain [1 ]
Wurch, Thierry [1 ]
Bailly, Christian [1 ]
Corvaia, Nathalie [1 ]
机构：
[1] CIPF, F-74160 St Julien En Genevois, France
来源：
NATURE REVIEWS IMMUNOLOGY | 2010年 / 10卷 / 05期
关键词：
MONOCLONAL-ANTIBODIES; CANCER-THERAPY; COLORECTAL-CANCER; DRUG; GLYCOSYLATION; BINDING; MOUSE; IDENTIFICATION; OPTIMIZATION; SPECIFICITY;
D O I：
10.1038/nri2747
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Antibodies and related products are the fastest growing class of therapeutic agents. By analysing the regulatory approvals of IgG-based biotherapeutic agents in the past 10 years, we can gain insights into the successful strategies used by pharmaceutical companies so far to bring innovative drugs to the market. Many challenges will have to be faced in the next decade to bring more efficient and affordable antibody-based drugs to the clinic. Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.
引用
收藏
页码：345 / 352
页数：8
相关论文
共 50 条
  • [41] Therapeutic antibodies and related products: choosing the right structure for success
    Beck, Alain
    Wagner-Rousset, Elsa
    Wurch, Thierry
    Corvaia, Nathalie
    M S-MEDECINE SCIENCES, 2009, 25 (12): : 1024 - 1032
  • [42] Anti-bacterial monoclonal antibodies: next generation therapy against superbugs
    Wang, Hui
    Chen, Daijie
    Lu, Huili
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2022, 106 (11) : 3957 - 3972
  • [43] Anti-bacterial monoclonal antibodies: next generation therapy against superbugs
    Hui Wang
    Daijie Chen
    Huili Lu
    Applied Microbiology and Biotechnology, 2022, 106 : 3957 - 3972
  • [44] Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
    Reynolds, Carson R.
    Tran, Son
    Jain, Mohit
    Narendran, Aru
    VACCINES, 2022, 10 (02)
  • [45] Engineering of single-domain antibodies for next-generation snakebite antivenoms
    Fernandes, Carla F. C.
    Pereira, Soraya S.
    Luiz, Marcos B.
    Silva, Nauanny K. R. L.
    Silva, Marcela Cristina S.
    Marinho, Anna Carolina M.
    Fonseca, Marcela H. G.
    Furtado, Gilvan Pessoa
    Trevizani, Raphael
    Nicolete, Roberto
    Soares, Andreimar M.
    Zuliani, Juliana P.
    Stabeli, Rodrigo G.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 185 : 240 - 250
  • [46] Therapeutic monoclonal antibodies and derivatives: Historical perspectives and future directions
    Rodgers, Kyla R.
    Chou, Richard C.
    BIOTECHNOLOGY ADVANCES, 2016, 34 (06) : 1149 - 1158
  • [47] Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies
    Lee, Ji-Hoon
    CANCER TREATMENT REVIEWS, 2024, 129
  • [48] Next Generation Digital Pathology: Emerging Trends and Measurement Challenges for Molecular Pathology
    Dexter, Alex
    Tsikritsis, Dimitrios
    Belsey, Natalie A.
    Thomas, Spencer A.
    Venton, Jenny
    Bunch, Josephine
    Romanchikova, Marina
    JOURNAL OF MOLECULAR PATHOLOGY, 2022, 3 (03): : 168 - 181
  • [49] Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges
    Luthra, Rajyalakshmi
    Chen, Hui
    Roy-Chowdhuri, Sinchita
    Singh, R. Rajesh
    CANCERS, 2015, 7 (04) : 2023 - 2036
  • [50] Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
    Arias-Pinilla, Gustavo A.
    Modjtahedi, Helmout
    CANCERS, 2021, 13 (08)
12345